Jim Cramer spoke with JJ Bienaimé for more on the company's newest drug that treats a very rare disease. » Read More
By: Elizabeth Gurdus
Jim Cramer looks ahead to a tidal wave of earnings and seeks out buying opportunities. » Read More
By: Michelle Fox
Infrastructure stocks have gotten a big boost after President Trump's election, but the run is "not even beginning," Mario Gabelli says. » Read More
By: Fred Imbert
Wall Street has raised its expectations for Amazon and Google's parent company, Alphabet, after they reported great earnings. » Read More
Fears that the tech sector is entering another bubble have been dismissed by analysts interviewed by CNBC
Some of the names on the move ahead of the open.
CNBC senior markets commentator Mike Santoli looks at the history of risk-adjusted returns to estimate what investors should reasonably expect from this bull market from here.
Dennis Gartman, Editor & Publisher of "The Gartman Letter" is perplexed by the current relationship between bonds & gold. He discusses his trade.
Victor Anthony of Axiom Capital initiates coverage of Netflix with a rare sell rating Monday. Here's why.
The Fed could pull the rug out from under investors who are overlooking signs an interest rate hike is coming, economist Carl Tannenbaum says.
Jim Cramer explained what makes a company the best in its sector and when to buy.
Jim Cramer shared his story of how learned to find an edge on stocks, and pay for his college education.
Jim Cramer shared his top rules to owning stocks based on a personal experience with his father.
Jim Cramer explained how the Great Recession changed his goals for "Mad Money."
Shares of Autodesk gained more than 8 percent Friday as analysts raised their price targets for the company.
Pure Storage shares stumble intraday after soaring 13 percent premarket following earnings beat.
Alere fell 3 percent after it sued Abbott to compel it to get all antitrust approvals required to complete its $5.8 billion merger.
Yellen and Fischer's comments at Jackson Hole leave markets right where they started the session.
Shareholders went nuts when jeweler Signet paid $1.4 billion for Zales in 2014. Now it's unraveling, sparking a surprise injection of costly private equity.
Bill Ackman tells CNBC the past 12 months were the "worst period of performance" of his career, and the implosion of Valeant Pharmaceuticals was mostly to blame.
Ulta gave third-quarter guidance below analyst expectations, despite reporting earnings and sales growth that topped estimates.
CNBC Pro highlights the top-performing stocks this week and analyzes whether the good times will continue.
Zev Spiro of Orips Research tells CNBC why he believes oil could rise above $70.
Telsey Advisory Group lowers its rating for Viacom, citing the prospects of a credit rating downgrade or dividend cut.
Get the best of CNBC in your inbox